Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1238)	10/21/2002 7:00:42 PM
From: tuck	Read Replies (1) \| Respond to of 1784

More trickle support from Apogent: >>PORTSMOUTH, N.H., Oct 21 (Reuters) - Apogent Technologies Inc. (NYSE:AOT - News), a leading manufacturer of laboratory and life science products, said on Monday that it slightly raised its guidance for the fiscal year ending September 2003. The company said it is now forecasting fiscal 2003 earnings per share of $1.37 to $1.44. This guidance does not reflect the benefits anticipated from additional share repurchases or new acquisitions. Thomson First Call published analysts' consensus earnings per share estimates of $1.40. "Revenues for fiscal 2003 are expected to be approximately 8 to 10 percent higher than fiscal 2002," Apogent President and Chief Executive Frank Jellinek Jr. said. "Operating margins are expected to be maintained or slightly enhanced as the year progresses, and our balance sheet is expected to grow even stronger." The company is expecting earnings per share of 28 to 29 cents for the first quarter including $2 million to $3 million of expenses for relocation of a facility. Apogent said it will release its full results for the fiscal year ended September 30, 2002, on Thursday, November 14, 2002, after the close of market.<< Cheers, Tuck